Glasziou, Paul; Haas, Marion - Centre for Health Economics Research & Evaluation … - 1994
This analysis compared the costs and benefits of tamoxifen for women with early breast cancer. The main question … addressed was: what are the costs and benefits of the use of tamoxifen as an adjuvant treatment in terms of survival and disease … tamoxifen and the control group was measured as a difference in QALYs gained. On average, women treated with tamoxifen gained 0 …